Related Experiment Video
Updated: Feb 15, 2026

Photo-Induced Cross-Linking of Unmodified Proteins PICUP Applied to Amyloidogenic Peptides
Published on: January 12, 2009
Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide
Eman A Elbassuoni1, Neven M Aziz1, Nashwa F El-Tahawy2
1a Physiology Department, Minia University Faculty of Medicine, Minia 61111, Egypt.
Abstract:
Diabetic nephropathy one of the major microvascular diabetic complications. Besides hyperglycemia, other factors contribute to the development of diabetic complications as the proinsulin connecting peptide, C-peptide. We described the role of C-peptide replacement therapy on experimentally induced diabetic nephropathy, and its potential mechanisms of action by studying the role of nitric oxide (NO) as a mediator of C-peptide effects by in vivo modulating its production by NG-nitro-l-arginine methyl ester (L-NAME). Renal injury markers measured were serum urea, creatinine, tumor necrosis factor alpha, and angiotensin II, and malondialdehyde, total antioxidant, Bcl-2, and NO in renal tissue. In conclusion, diabetic induction resulted in islet degenerations and decreased insulin secretion with its metabolic consequences and subsequent renal complications. C-Peptide deficiencies in diabetes might have contributed to the metabolic and renal error, since C-peptide treatment to the diabetic rats completely corrected these errors. The beneficial effects of C-peptide are partially antagonized by L-NAME coadministration, indicating that NO partially mediates C-peptide effects.
Insights
C-peptide replacement therapy effectively reverses diabetic nephropathy complications in rats. Nitric oxide (NO) partially mediates these beneficial effects, highlighting a potential therapeutic pathway for diabetic kidney disease.
Area of Science:
- Nephrology
- Endocrinology
- Biochemistry
Background:
- Diabetic nephropathy is a major microvascular complication of diabetes.
- Factors beyond hyperglycemia, such as C-peptide, contribute to diabetic complications.
- C-peptide's role in diabetic nephropathy and its mechanisms require further elucidation.
Purpose of the Study:
- To investigate the therapeutic effects of C-peptide replacement therapy on experimentally induced diabetic nephropathy.
- To explore the role of nitric oxide (NO) as a mediator in C-peptide's protective actions.
- To assess the impact of C-peptide on renal injury markers and oxidative stress.
Main Methods:
- Diabetic nephropathy was induced in rats.
- C-peptide replacement therapy was administered.
- Nitric oxide production was modulated using NG-nitro-l-arginine methyl ester (L-NAME).
- Renal injury markers (serum urea, creatinine), inflammatory markers (TNF-α, Angiotensin II), oxidative stress markers (MDA, total antioxidant), and NO levels were measured in renal tissue.
Main Results:
- Diabetic induction led to islet degeneration, reduced insulin secretion, and subsequent renal complications.
- C-peptide treatment significantly corrected metabolic and renal errors in diabetic rats.
- Co-administration of L-NAME partially reversed the beneficial effects of C-peptide, indicating NO mediation.
- C-peptide therapy improved renal function and reduced oxidative stress.
Conclusions:
- C-peptide deficiency may contribute to metabolic and renal dysfunction in diabetes.
- C-peptide replacement therapy demonstrates significant renoprotective effects in experimental diabetic nephropathy.
- Nitric oxide partially mediates the beneficial effects of C-peptide, suggesting a therapeutic link.
Related Concept Videos
Peptide Bonds
Nitric Oxide Signaling Pathway
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Oxidation Numbers
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

